Find and Pitch Jounalists, Get Your Story Covered

Tags: rifaximin lactulose hepatic encephalopathy respiratory insufficiency spontaneous bacterial peritonitis

	Profile	Recent Articles on Subject
1	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	First Generics for Low-Dose Rivaroxaban Get FDA Approval - 6 days ago OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link? - over 1 year ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Novartis secures MHRA authorisation for ribociclib - about 1 month ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval - 4 months ago
4	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Rifaximin Reduced Overt Hepatic Encephalopathy Recurrence Over Lactulose - 4 months ago
5	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - 4 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Oral Sulopenem Etzadroxil and Probenecid for Uncomplicated Urinary Tract Infections - 5 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 9 months ago FDA Approves Adalimumab-ryvk as Interchangeable Biosimilar for Humira - about 1 year ago No Difference Observed Between Branded, Biosimilar Enoxaparin for Post-Operative Thrombosis - about 1 year ago Doxycycline for Treatment of Pneumococcal Infection Could Reduce Clostridioides difficile Infection - about 1 year ago FDA Approves Defencath for Catheter-Related Infections for Those With Kidney Failure - over 1 year ago Arexvy Shows Non-Inferior Immune Response Against Lower Respiratory Tract Disease From RSV - over 1 year ago RBX2660 Leads to Recurrent-Free Outcomes for Patients With Clostridioides difficile Infection - over 1 year ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Gepotidacin Receives FDA Priority Review for the Treatment of Uncomplicated Urinary Tract Infections - 5 months ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 6 months ago STAT+: FDA cites cancer links in seeking to withdraw approval of antibiotic used in pigs - over 1 year ago STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation - over 1 year ago
9	Katherine Kahn MedPage Today Physician-Scientist. Studies Long Covid. United States medicineLong Covid	In-Hospital Infections, Antimicrobial Resistance Declined Over 13 Years - 7 months ago Antimicrobial Resistance Must Be Addressed Now, Global Experts Warn - 10 months ago Paxlovid Fails to Shorten COVID in Standard-Risk and Vaccinated At-Risk Patients - 11 months ago Use These Antibiotics for Close Contacts of Invasive Meningococcal Disease, CDC Says - about 1 year ago Why Aren't More Doctors Prescribing Paxlovid to High-Risk Patients? - about 1 year ago Paxlovid May Not Be Associated With Lower Long COVID Risk, Survey Suggests - about 1 year ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - 7 months ago Abelacimab Demonstrates Significant Reduction in Bleeding vs Rivaroxaban in Patients With Atrial Fibrillation - over 1 year ago

Journalists covering rifaximin